相关实验视频

Updated: Jan 7, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

针对B细胞的CAR-T疗法用于自身免疫性疾病

Qi Li¹, Ning Zhao¹, Ruitao Hou¹

¹Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, 200241, China.

Frontiers of medicine

|December 26, 2025

概括

化学抗原受体T (CAR-T) 细胞疗法有效地向癌症和自身免疫性疾病的B细胞. 本综述探讨了CAR-T的进展,临床结果和自身免疫性疾病治疗的挑战.

科学领域:

免疫治疗是一种免疫疗法.
细胞疗法细胞疗法
自身免疫性疾病研究研究

背景情况:

化学抗原受体T (CAR-T) 细胞在消除B细胞恶性瘤方面表现出高效.
卡特-T细胞疗法提供了通过B细胞枯竭和重置来治疗自身免疫性疾病的潜力.
收养细胞治疗的应用正在扩大.

研究的目的:

审查CAR-T针对性B细胞治疗自身免疫疾病的进展情况.
检查新的治疗策略和临床结果.
确定CAR-T疗法的挑战和未来增强机会.

主要方法:

在自身免疫性疾病中对CAR-T细胞疗法的文献综述.
分析治疗策略和临床试验报告.
评估安全方面和技术限制.

主要成果:

卡尔-T细胞疗法显示出对B细胞恶性瘤的显著特异性和有效性.
B细胞的枯竭和CAR-T细胞的重置显示出对自身免疫性疾病的希望.
研究了CAR-T治疗自身免疫性疾病的临床结果和进展.

结论:

卡特-T细胞疗法是通过向B细胞来治疗自身免疫性疾病的一种有前途的方法.
需要进一步的研究来解决安全问题和局限性.
在CAR-T技术的进步可以提高治疗的有效性和适用性.

关键词:

自身免疫性疾病自身免疫性疾病仿制性抗原受体-T疗法临床应用临床应用免疫介导的化性肌肉病变.淋巴细胞的减少.多发性硬化症多发性硬化症肌痛性骨髓灰质炎 (Myasthenia Gravis) 是一个严重的疾病.类风湿性关节炎类风湿性关节炎系统性红血性狼 (Systemic Lupus Erythematosus) 是一种全身性狼.系统性硬化症系统性硬化症

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...